![](https://endpts.com/wp-content/uploads/2019/07/Lee-Kraus-UT-Southwestern-social-and-tile.jpg)
Lee Kraus, UT Southwestern
PARP inhibitors sometimes work beyond BRCA-mutations, researchers may finally know why
A class of potent cancer treatments could shine brighter than previously thought in a broader array of patients, new research suggests.
PARP inhibitors, including AstraZeneca …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.